Emerging Issues on Pharma Market
in Central Asia & South Caucasus
Kesarev, the leading government relations firm across Central Asia, Russia, CEE & the post-Soviet countries, will hold a 1-hour webinar on emerging regulatory issues on Central Asian (Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan) and South Caucasus (Armenia, Azerbaijan, Georgia) pharmaceutical markets.

Kesarev experts will share their views on the following regulatory issues across the region:

  • Pricing. State regulation of prices for both medicines sold through government procurement and by retail (in pharmacies).
  • Tagging. The procedure of tagging of drugs and medical devices.
  • Single market. Single pharmaceutical market of the Eurasian Economic Union (EAEU): prospects of compliance of the national member-state regulations with the single EAEU requirements.
  • Mutual recognition procedure (MRP). Future of MRP between Central Asian countries and Russia.
  • Protectionism. Policy of protectionism in the pharmaceutical sector, including requirements for the localization of production, interstate integration processes and sanctions.
  • COVID-19. Impact of the pandemic on the intergovernmental trade on vaccines and test system.

October 5, 2021
10:00 am Brussels time
11:00 am Moscow time
2:00 pm Nur-Sultan time


10:00-10:05 / 11:00-11:05 / 14:00-14:05 - Opening remarks by Pavel Melnikov, Partner

10:05-10:25 / 11:05-11:25 / 14:05-14:25 - Presentation on South Caucasus countries by Daniyar Koshenov, Co-Head of Kazakhstan & Central Asia

10:25-10:45 / 11:25-11:45 / 14:25-14:45 - Presentation on Central Asian countries by Natalia Malyarchuk, Director in Kazakhstan & Central Asia

10:45-11:00 / 11:45-12:00 / 14:45-15:00 - Discussion and Q&A session

The event will be held in English.

Register now by sending email to events@kesarev.com by EOB October 4, 2021

In case you need to double check details of the webinar please read the full invitation.

Natalia Malyarchuk

Natalia is a Senior Counsel and Director for Kazakhstan & Central Asia in Kesarev. She has played an instrumental role in the establishment of the practice across Central Asia. Natalia advises a range of Fortune-500 clients, including those operating in the pharma market, on the nuances of regulatory and political developments across Central Asia.

Daniyar Koshenov

Daniyar is a Senior Counsel and Co-Head of Kazakhstan & Central Asia Practice in Kesarev. He has over 10 years of experience in regulatory and public affairs management in Central Asia, for transnational companies in highly regulated industries, including the pharmaceutical sector. Daniyar has vast experience in coordinating and implementing global government relations campaigns at the local level and co-leads the coordination of Kesarev's growing operations in Central Asia and the South Caucasus countries.
About Kesarev

Kesarev is the largest independent consultancy in Russia, the post-Soviet region, Central & Eastern Europe, Turkey, and Israel, covering 25 countries and specialising in government relations services, risk and corporate reputation management. Kesarev serves clients in the agribusiness/food sector, healthcare, FMCG, financial services, ICT, infrastructure, energy/utility, mining/natural resources.